Plaque detection using intraoral scanning
ISRCTN | ISRCTN11821756 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN11821756 |
IRAS number | 334049 |
Secondary identifying numbers | IRAS 334049 |
- Submission date
- 18/06/2024
- Registration date
- 04/07/2024
- Last edited
- 12/11/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Oral Health
Plain English Summary
Background and study aims
Plaque is microbial biofilms on surfaces such as teeth that can cause local inflammatory reactions and on a long-term, can lead to oral diseases. In routine clinical practice, dental professionals typically detect plaque by visual examination aided by a dental explorer. Plaque is generally colorless, and can be visualized by staining with a disclosing agent. DAs are special dyes that adhere to the biofilm and contrasts the plaque with color to the white tooth surface. When clinically assessing plaque, the assessment can be supported by using an index - many of these are, however, used more for research than in routine clinical practice.
The general routine clinical procedure for plaque detection has disadvantages such as lack of recording of clinical findings in images and dependency of examiner's skills.
Development of non-invasive techniques independent of human error to assist in plaque detection would have great benefit.
This study is about comparing current standard practice with plaque detection on different modality (3D scans).
Who can participate?
Any adult (over 18 years) can participate, as the study is involving a broad section of the population.
What does the study involve?
The patient will be checked to see if they meet the necessary conditions to be part of the study. They might have different amounts of plaque on their teeth. The dentist will then use special 3D scanning equipment, which is approved for dental use, to take detailed images of the inside of the patient's mouth. After that, the dentist will measure the amount of plaque using a standard method called the Silness & Löe index, which involves looking at the teeth and gums.
Next, the dentist will apply a special dye to the patient's teeth that makes the plaque visible by coloring it. The dentist will take another 3D scan of the teeth with the colored plaque and again measure the plaque using the Silness & Löe index.
In addition to examining the patient's teeth directly, the dentist will also measure the plaque by looking at the 3D scan images. One week later, the dentist will reassess the plaque using the same 3D scan images. Another dentist, who does not know the results of the previous examinations, will also evaluate the plaque on the 3D scan images.
What are the possible benefits and risks of participating?
The benefits of participating are that participants may discover a condition in their mouth they were otherwise unaware of. They will also potentially obtain a better understanding of the importance of good oral hygiene. The risks are that a small number of persons feel the scanner can be uncomfortable if it gets warm. There is also a very small risk that a participant is allergic to the disclosing agent without knowing in advance.
Where is the study run from?
Dental School at University of Bristol (UK)
When is the study starting and how long is it expected to run for?
January 2024 to March 2025
Who is funding the study?
The Danish medical device company, 3Shape
Who is the main contact?
Professor Nicola West, N.X.West@bristol.ac.uk
Contact information
Public, Scientific, Principal Investigator
Lower Maudlin Street
Bristol
BS1 2LY
United Kingdom
Phone | +44 (0)117 342 9638 |
---|---|
N.X.West@bristol.ac.uk |
Study information
Study design | Non-randomized and non-interventional single-center cohort study |
---|---|
Primary study design | Observational |
Secondary study design | Cohort study |
Study setting(s) | University/medical school/dental school |
Study type | Diagnostic |
Participant information sheet | Not available in web format, please use contact details to request a participant information sheet. |
Scientific title | Investigating the utility of 3D-intraoral scan imaging to score plaque compared to clinical visual assessment |
Study acronym | Nil known |
Study hypothesis | To assess the accuracy of intraoral 3D scanner-derived detection by dichotomous outcome (yes/no) of plaque compared to the standard clinical visually-derived direct scoring of plaque. |
Ethics approval(s) |
Approved 10/06/2024, Yorkshhire & The Humber - Bradford Leeds Research Ethics Committee (Holland Drive, Newcastle upon Tyne, NE2 4NQ, United Kingdom; +44 2071048083; bradfordleeds.rec@hra.nhs.uk), ref: 334049 |
Condition | Dental plaque in a variety amount present |
Intervention | The patient will be screened according to the inclusion and exclusion criteria - they may have varying degrees of plaque. The clinician will then perform the 3D intraoral scan (using CE-marked equipment within its intended purpose), and the clinician will then perform a standard plaque indexing using the Silness & Löe index for visual examination. The patient will then get applied a disclosing agent to the teeth, colorizing the plaque. They will get another 3D scan of the disclosed teeth, and the dentist will perform the Silness & Löe plaque index on the disclosed teeth. Without involving the patient, the clinician will also perform the plaque index examination directly on the scan. One week later, the clinician will score the plaque directly on the scan once more. Another clinician, blinded to the clinical truth, will also perform the plaque assessment on the scan. |
Intervention type | Device |
Pharmaceutical study type(s) | Not Applicable |
Phase | Not Applicable |
Drug / device / biological / vaccine name(s) | Trios 5 intraoral scanner |
Primary outcome measure | Plaque measured using intraoral 3D scanner and standard clinical visually-derived direct scoring at baseline and 1 week |
Secondary outcome measures | To compare the performance of an algorithm detecting visible plaque to the clinical visual assessment of plaque and the 3D scan-derived assessment |
Overall study start date | 02/01/2024 |
Overall study end date | 03/03/2025 |
Eligibility
Participant type(s) | Healthy volunteer |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Upper age limit | 100 Years |
Sex | Both |
Target number of participants | 60 |
Participant inclusion criteria | 1. Participant is willing and able to give informed consent for participation in the study 2. Male or Female, adults aged 18 years or above 3. A minimum of 20 natural teeth present (10 teeth in each jaw) 4. Able (in the Investigators opinion) and willing to comply with all study requirements |
Participant exclusion criteria | Presence of orthodontic brackets or clear aligner attachments |
Recruitment start date | 27/06/2024 |
Recruitment end date | 11/11/2024 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Tyndall Avenue
Bristol
BS8 1TH
United Kingdom
Sponsor information
Industry
Holmens Kanal 7
Copenhagen
1060
Denmark
Phone | +45 30952141 |
---|---|
josefine.jensen@3shape.com | |
Website | https://www.3shape.com/ |
https://ror.org/042cmjn68 |
Funders
Funder type
Industry
No information available
Results and Publications
Intention to publish date | 18/10/2025 |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Data sharing statement to be made available at a later date |
Publication and dissemination plan | Planned publication in a peer-reviewed journal. |
IPD sharing plan | The data-sharing plans for the current study are unknown and will be made available at a later date. |
Editorial Notes
12/11/2024: The following changes were made to the trial record:
1. The secondary outcome measures were added.
2. The recruitment end date was changed from 03/01/2025 to 11/11/2024.
19/06/2024: Trial's existence confirmed by Yorkshhire & The Humber - Bradford Leeds Research Ethics Committee.